BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34717838)

  • 1. Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].
    Hua X; Liu Z; Zhou M; Tian Y; Zhao PP; Pan WH; Li CX; Huang XX; Liao ZX; Xian Q; Chen B; Hu Y; Leng L; Fang XW; Yu LN
    EBioMedicine; 2021 Oct; 72():103665. PubMed ID: 34717838
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN.
    Hua X; Liu Z; Zhou M; Tian Y; Zhao PP; Pan WH; Li CX; Huang XX; Liao ZX; Xian Q; Chen B; Hu Y; Leng L; Fang XW; Yu LN
    EBioMedicine; 2019 Dec; 50():178-190. PubMed ID: 31727599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
    Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
    Front Genet; 2020; 11():1030. PubMed ID: 33101368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
    Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
    EBioMedicine; 2024 May; 103():105106. PubMed ID: 38579361
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA ADAMTS9-AS1 inhibits the progression of prostate cancer by modulating the miR-142-5p/CCND1 axis.
    Zhou Z; Wu X; Zhou Y; Yan W
    J Gene Med; 2021 May; 23(5):e3331. PubMed ID: 33704879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
    Fu A; Yu Z; Zhang E; Song J
    Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.
    Zhu X; Ma X; Zhao S; Cao Z
    Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction notice to "Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter" [EBioMedicine 55 (2020) 102694].
    Ou M; Li X; Zhao S; Cui S; Tu J
    EBioMedicine; 2024 Jun; 104():105193. PubMed ID: 38833838
    [No Abstract]   [Full Text] [Related]  

  • 10. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
    Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
    Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
    Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
    EBioMedicine; 2024 May; 103():105105. PubMed ID: 38579362
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression.
    Deng J; Zhang Q; Lu L; Fan C
    Cancer Manag Res; 2020; 12():2947-2960. PubMed ID: 32431541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p.
    Li L; Chen P; Huang B; Cai P
    Oncol Lett; 2021 Dec; 22(6):825. PubMed ID: 34691252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
    Cheng Z; Jiang S; Tao R; Ge H; Qin J
    Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction notice to "CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183" [Life Sci. 241 (2020) 117097].
    Jin C; Zhao W; Zhang Z; Liu W
    Life Sci; 2020 Sep; 256():117904. PubMed ID: 32563538
    [No Abstract]   [Full Text] [Related]  

  • 19. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis.
    Wei P; Yang J; Zhang D; Cui M; Li L
    Onco Targets Ther; 2020; 13():4523-4531. PubMed ID: 32547083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis.
    Fang J; Jiang G; Mao W; Huang L; Huang C; Wang S; Xue H; Ke J; Ni Q
    Bioengineered; 2022 Feb; 13(2):3707-3723. PubMed ID: 35094653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.